"serum-institute"

While BioE3 policy is a promising step, attracting investment and collaborations are a must

While development of a dengue vaccine has been perennially in the making, the recent launch of the third phase of clinical trials of dengue vaccine in India by ICMR with Panacea Biotec, has raised hopes over the availability of a dengue vaccine to the general public in the next few years.

Former Director General of ICMR, Dr Balram Bhargava said that initial signs of the recent rise of Covid cases clearly indicate mild infections

Along with Serum Institute (AS), the DBT on Thursday announced the launch of the indigenously made cervical cancer vaccine.

The daily vaccination rate has fallen to 1.3 million doses despite India not exporting the vaccines now

The Minister spoke about his personal isolation experience to the decision on imposing lockdown, vaccine for children to India seeking help from other countries, among other things

States may face delays in getting approvals from Indian drug regulatory authorities

The SII has announced a compensation of Rs 25 lakhs each to the families of deceased.

Health Minister Rajesh Tope and Pune Mayor Murlidhar Mohol announced that five persons, including one woman, had perished in the blaze and their bodies were found during the cooling operations.

At least 10 fire-tenders from Pune Fire Brigade rushed to the site and were battling the blaze, the cause of which is not clear.

Zilla Parishad Chairperson Roja Sharma was speaking after launching the vaccination drive at Area Hospital, Siddipet on Saturday

58 healthcare centres ready to provide emergency services to individuals with Adverse Events Following Immunisation across State

3.64 lakh vials reach storage facility in Koti; all set for roll out on Jan 16

The Pfizer-BioNTech jab is one of several vaccines bringing hope for an end to the pandemic that has killed more than 1.5 million people worldwide and ravaged economies.

The SII has rejected charges of side effects claimed by a vaccine trial participant who also sought damages of Rs 5 crore

The Oxford-AstraZeneca vaccine is being made in partnership with Serum Institute.

SII and ICMR are conducting phase II/III clinical trial of the vaccine at 15 different centres across the country.